Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/18720
Title: Prevention of sepsis prior to prostate biopsy.
Authors: Toner, Liam;Bolton, Damien M;Lawrentschuk, Nathan L
Affiliation: Department of Surgery, Urology Unit, University of Melbourne, Melbourne, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
School of Cancer Medicine, La Trobe University, Melbourne, Australia
Issue Date: Mar-2016
EDate: 2016-03-11
Citation: Investigative and clinical urology 2016; 57(2): 94-9
Abstract: Urosepsis is the most feared complication of transrectal prostate biopsy. The incidence may be increasing from <1% to 2%-3% in contemporary series. Historically, fluoroquinolones have been effective antibiotic prophylaxis to prevent infective complications but antibiotic resistance is increasing. The increase in antibiotic resistance may contribute to reported increases in urosepsis and hospitalization after transrectal biopsy. This article will review other methods clinicians may employ to reduce the incidence of infective complications after prostate biopsy. A systematic review of the literature was conducted using literature databases PubMed and Ovid MEDLINE in August 2015 in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) criteria. Effective strategies to reduce infective complications after transrectal prostate biopsy include augmented prophylaxis with other antibiotics, rectal swab culture directed antibiotic prophylaxis or a transperineal biopsy approach. Needle disinfection, minimizing the number of biopsy needles and rectal disinfectants may also be of use. These methods may be of particular utility in patients with risk factors for developing urosepsis such as recent antibiotic use and overseas travel. The scientific literature describes various techniques designed to reduce infective complications caused by prostate biopsy. Clinicians should consider incorporating these novel techniques into their contemporary practice.
URI: http://ahro.austin.org.au/austinjspui/handle/1/18720
DOI: 10.4111/icu.2016.57.2.94
ORCID: 0000-0001-8553-5618
PubMed URL: 26981590
Type: Journal Article
Review
Subjects: Biopsy
Complications
Infection
Prostatic neoplasms
Sepsis
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.